To help BARDA be prepared for any public health emergency by identifying and derisking the world's most promising technologies and capabilities, no matter their origin, towards the development of tomorrow's medical countermeasures.


To ensure the most effective life-saving medical countermeasures are developed for, available to, and used by everyone who needs them when they need them.

Unique public-private partnerships, new authorities, and an ecosystem of restless innovation.

The Drive Business Model

DRIVe is forming unique public-private partnerships. DRIVe will leverage new authorities given to BARDA under the 21st Century Cures Act to stimulate innovation through both non-dilutive funding and dilutive funding. In addition, through our DRIVe Accelerator Network, we will have teams forward deployed throughout the USA to identify promising solutions wherever innovation is happening. Together we are building out an ecosystem of restless innovation, driven by industry and the entrepreneurial community, to address our nation's largest health security threats.

Responsive Frameowrk


Established in 2006, the mission of the Biomedical Advanced Research and Development Authority (BARDA) is to develop and procure medical countermeasures, vaccines, drugs, therapeutics, diagnostic tools, and nonpharmaceutical products, that address the public health and medical consequences of chemical, biological, radiological, and nuclear (CBRN) accidents, incidents, and attacks, pandemic influenza, and emerging infectious diseases. Specifically, BARDA supports the advanced development and procurement of drugs, vaccines, and other products that are considered priorities for responding to and recovering from threats to American national health security. To date, the medical countermeasures and products in this diverse portfolio have received a total of 85 FDA approvals, licensures, or clearances.